未登录.png)
分享.png)
收藏Treatment of an adult patient with severe dental crowding by applying asymmetric extraction, fixed appliance, and micro-implant anchorage: a case report采用不对称拔牙、固定矫治器和微种植体支抗治疗成人严重牙列拥挤：一例病例报告
Xue, Huixin; Xu, Siyi; Qi, Yezi; Xue, Leilei; Ni, Xinxin; Xu, Liqi; Li, Qingshan; Lin, Jun 分享 收藏 分享 收藏 A plain language summary of results from the TORCHLIGHT trial of toripalimab plus chemotherapy for metastatic or recurrent triple-negative breast cancerJiang, Zefei; Ouyang, Quchang; Sun, Tao; Zhang, Qingyuan; Teng, Yuee; Cui, Jiuwei; Wang, Haibo; Yin, Yongmei; Wang, Xiaojia; Zhou, Xin; Wang, Yongsheng; Sun, Gang; Wang, Jingfen; Zhang, Lili; Yang, Jin; Qian, Jun; Yan, Min; Liu, Xinlan; Yi, Tienan; Cheng, Ying; Li, Man; Zang, Aimin; Wang, Shusen; Wang, Chuan; Wu, Xinhong; Cheng, Jing; Li, Hui; Lin, Ying; Geng, Cuizhi; Gu, Kangsheng; Xie, Chunwei; Xiong, Huihua; Wu, Xiaohong; Yang, Junlan; Li, Qingshan; Chen, Yiding; Li, Fanfan; Zhang, Anqin; Zhang, Yongqiang; Wu, Yudong; Nie, Jianyun; Liu, Qiang; Wang, Kun; Mo, Xueli; Chen, Lilin; Pan, Yueyin; Fu, Peifen; Zhang, Helong; Pang, Danmei; Sheng, Yuan; Han, Yunwei; Wang, Hongxia; Cang, Shundong; Luo, Xianming; Yu, Wenbo; Deng, Rong; Yang, Chaoqiang; Keegan, Patricia 分享 收藏 分享 收藏 Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China卡多尼单抗联合铂类化疗加或不加贝伐单抗作为一线治疗持续性、复发性或转移性宫颈癌 (COMPASSION-16): 一项随机、双盲、安慰剂对照的中国3期临床试验Wu, Xiaohua; Sun, Yang; Yang, Hongying; Wang, Jing; Lou, Hanmei; Li, Dan; Wang, Ke; Zhang, Hui; Wu, Tao; Li, Yuzhi; Wang, Chunyan; Li, Guiling; Wang, Yifeng; Li, Dapeng; Tang, Ying; Pan, Mei; Cai, Hongyi; Wang, Weihu; Yang, Bing; Qian, Hua; Tian, Qiuhong; Yao, Desheng; Cheng, Ying; Wei, Bing; Li, Xiumin; Wang, Tao; Hao, Min; Wang, Xiaohong; Wang, Tiejun; Ran, Juntao; Zhu, Hong; Zhu, Lijing; Liu, Xianling; Li, Yunxia; Chen, Lihong; Li, Qingshan; Yan, Xiaojian; Wang, Fei; Cai, Hongbing; Zhang, Yunyan; Liang, Zhiqing; Liu, Funan; Huang, Yi; Xia, Bairong; Qu, Pengpeng; Zhu, Genhai; Chen, Youguo; Song, Kun; Sun, Meili; Chen, Zhengzheng; Zhou, Qiang; Hu, Lina; Abulizi, Guzhalinuer; Guo, Hongyan; Liao, Sihai; Ye, Yijing; Yan, Ping; Tang, Qiu; Sun, Guoping; Liu, Ting; Lu, Dongmei; Hu, Mingxiu; Wang, Zhongmin M.; Li, Baiyong; Xia, Michelle 分享 收藏 分享 收藏 分享 收藏 Open-label, single-arm, multicenter, phase 2 trial of garsorasib in KRAS G12C-mutated non-small-cell lung cancerLi, Ziming; Dang, Xiaomin; Huang, Dingzhi; Jin, Shi; Li, Weiwei; Shi, Jianhua; Wang, Xicheng; Zhang, Yiping; Song, Zhengbo; Zhang, Junping; Zhuang, Wu; Liu, Xuewen; Jiang, Liyan; Meng, Xiangjiao; Zhao, Mingfang; Zhou, Jianying; Zhang, Liangming; Wang, Pingli; Luo, Hui; Yang, Junquan; Cang, Shundong; Wang, Xiang; Wang, Jing; Cui, Jiuwei; Yu, Yan; Zhang, Zhihong; Lu, Junguo; Yang, Weihua; Li, Gaofeng; Feng, Jifeng; Lv, Dongqing; Wu, Lin; Fang, Yong; Wang, Yan; Zhao, Yanqiu; Cao, Baoshan; Zhu, Wei; Zhuang, Zhixiang; Li, Qingshan; Wang, Mingxi; Zhou, Huan; Dong, Xiaorong; Hu, Sheng; Fang, Jian; Zhang, Yihong; Wang, Wenjia; Xiang, Ziyong; Shi, Zhe; Zhang, Ling; Lu, Shun 分享 收藏 CD36 inhibition reduces non-small-cell lung cancer development through AKT-mTOR pathwayLiu, Hui; Guo, Wentong; Wang, Tianxiang; Cao, Peichang; Zou, Tingfeng; Peng, Ying; Yan, Tengteng; Liao, Chenzhong; Li, Qingshan; Duan, Yajun; Han, Jihong; Zhang, Baotong; Chen, Yuanli; Zhao, Dahai; Yang, Xiaoxiao 分享 收藏 Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trialToripalimab联合nab-紫杉醇治疗转移性或复发性三阴性乳腺癌: 一项随机3期试验Jiang, Zefei; Ouyang, Quchang; Sun, Tao; Zhang, Qingyuan; Teng, Yuee; Cui, Jiuwei; Wang, Haibo; Yin, Yongmei; Wang, Xiaojia; Zhou, Xin; Wang, Yongsheng; Sun, Gang; Wang, Jingfen; Zhang, Lili; Yang, Jin; Qian, Jun; Yan, Min; Liu, Xinlan; Yi, Tienan; Cheng, Ying; Li, Man; Zang, Aimin; Wang, Shusen; Wang, Chuan; Wu, Xinhong; Cheng, Jing; Li, Hui; Lin, Ying; Geng, Cuizhi; Gu, Kangsheng; Xie, Chunwei; Xiong, Huihua; Wu, Xiaohong; Yang, Junlan; Li, Qingshan; Chen, Yiding; Li, Fanfan; Zhang, Anqin; Zhang, Yongqiang; Wu, Yudong; Nie, Jianyun; Liu, Qiang; Wang, Kun; Mo, Xueli; Chen, Lilin; Pan, Yueyin; Fu, Peifen; Zhang, Helong; Pang, Danmei; Sheng, Yuan; Han, Yunwei; Wang, Hongxia; Cang, Shundong; Luo, Xianming; Yu, Wenbo; Deng, Rong; Yang, Chaoqiang; Keegan, Patricia 分享 收藏 分享 收藏 分享 收藏 分享 收藏 6-Methyl flavone inhibits Nogo-B expression and improves high fructose diet-induced liver injury in miceGong, Ke; Zhang, Zhen; Chen, Sha-sha; Zhu, Xin-ran; Wang, Meng-yao; Yang, Xin-yue; Ding, Chen; Han, Ji-hong; Li, Qing-shan; Duan, Ya-jun 分享 收藏 分享 收藏 First-in-human phase I/Ib study of QL1706 (PSB205), a bifunctional PD1/CTLA4 dual blocker, in patients with advanced solid tumors双功能PD1/CTLA4双重阻滞剂QL1706 (PSB205) 在晚期实体瘤患者中的首次人体I/Ib期研究Zhao, Yuanyuan; Ma, Yuxiang; Zang, Aimin; Cheng, Ying; Zhang, Yiping; Wang, Xiangcai; Chen, Zhendong; Qu, Song; He, Jianbo; Chen, Chuanben; Jin, Chuan; Zhu, Dongyuan; Li, Qingshan; Liu, Xianling; Su, Wuyun; Ba, Yi; Hao, Yanrong; Chen, Junmin; Zhang, Guoping; Qu, Shenhong; Li, Yong; Feng, Weineng; Yang, Mengxiang; Liu, Baorui; Ouyang, Weiwei; Liang, Jin; Yu, Zhuang; Kang, Xiaoyan; Xue, Shilin; Yang, Guihong; Yan, Wei; Yang, Yingying; Liu, Zhi; Peng, Yufeng; Fanslow, Bill; Huang, Xian; Zhang, Li; Zhao, Hongyun 分享 收藏 分享 收藏 Efficacy and Safety of Denosumab Biosimilar QL1206 Versus Denosumab in Patients with Bone Metastases from Solid Tumors: A Randomized Phase III TrialLi, Huiping; Huang, Yan; Chen, Zhendong; Zeng, Aiping; Zhang, Helong; Yu, Yan; Wei, Shihong; Li, Qingshan; Wang, Xiaojia; Wang, Xiangcai; Wang, Xiuwen; Yang, Runxiang; Dai, Xiumei; Bi, Minghong; Sun, Tao; Zhang, Qingyuan; Han, Cuicui; Li, Yujie; Kang, Xiaoyan; Liu, Yaxin; Zhang, Li 分享 收藏 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png)
LANCET.png)
